Bristol hires ImClone manufacturing exec
Executive Summary
ImClone Senior VP-Manufacturing Operations & Product Development Joseph Tarnowski will join Bristol-Myers Squibb as senior VP-biologics, manufacturing and process development. ImClone VP-Manufacturing Richard Crowley will take over for Tarnowski as senior VP- biopharmaceutical operations, overseeing the company's biologics manufacturing operations. Crowley joined ImClone in 2000 as assistant VP-manufacturing and was promoted to VP-manufacturing in 2002. Prior to joining ImClone, Crowley held positions at BASF, Genencor International, Eastman Kodak and Monsanto...
You may also be interested in...
Submitting A Non-COVID-19 Product For FDA Review? Then Take A Seat, It’s Gonna Be Awhile
Top US FDA device center officials Jeff Shuren and William Maisel said in a 15 April blog post that manufacturers should expect a delay in the review of new product submissions thanks to the pandemic. They noted that the agency also won’t be accepting certain IVD pre-submission requests until next year.
Prescience Point Capital Launches Proxy Fight To Change MiMedx's Board
Prescience Point Capital is trying to reshuffle the board of directors leading regenerative medicine company MiMedx, arguing the company’s current board has destroyed shareholder value. The company's tock is selling for about a third of its potential value, according to Prescience.
In Flood Of 2020 Sanitizer Launches, Unilever’s Suave Brand Tops US Category Sales
Unilever’s Suave brand led new sanitizer product sales in 2020, when hand sanitizers total sales grew 569%, according to IRI. Sales of rinseable hand-soap sales grew 64% and antiseptics 19%.